Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

10-Aug-2006

  • Study backs lower PSA threshold for black men (Reuters via Yahoo! News)

    African-American men with early nonpalpable prostate cancer have greater tumor volume than white men with similar prostate specific antigen (PSA) levels, a study shows. This suggests that the threshold for PSA should be lowered in black men.


  • Paul Grainger, a warehouse operative, is raising awareness about prostate cancer (Guardian Unlimited)

    Paul Grainger, a warehouse operative, is raising awareness in his workplace about prostate cancer.


  • Building Factory a Balancing Act for Dendreon (RedNova)

    By Luke Timmerman, The Seattle Times Aug. 9--Dendreon has a Goldilocks dilemma: It can't afford to overbuild its factory, or to underbuild. To make its prostate-cancer drug succeed, it must predict factory needs just right -- before it even has permission to sell the drug.


  • Prostate Cancer Hits One in Six Men, Fuels Angst Over Testing (Bloomberg.com)

    Aug. 8 (Bloomberg) -- One day in Chicago, Dave Bigg is about to drink a few beers with his buddies and divvy up Cubs baseball tickets when his cell phone rings. It's the doctor, and he doesn't like what he sees. Bigg's biopsy looks bad. The cells from his prostate are warped and buckled.


  • Hospital offers free prostate screenings (Port Clinton News Herald)

    The Bellevue Hospital is sponsoring a free prostate cancer screening from 8 to 11 a.m. Saturday, Sept. 9 in the Specialty Care Services Area of the hospital, 1400 W. Main St. Appointments are required and may be made by calling (419) 483-4040, ext. 4326. Appointments can be made beginning Aug. 16.


  • A New Way To Fight Lung Cancer (WCCO Minneapolis/St. Paul)

    Lung cancer kills more people than breast, colon and prostate cancers combined. Yet sometimes doctors hold back on the chemotherapy to see if surgery alone can knock it out. Watch The Video More Health News


  • Generex expands vaccine trials to include prostate cancer (Pharmaceutical Business Review)

    Generex Biotechnology has entered into an agreement with the Euroclinic in Athens, Greece to commence clinical trials to evaluate AE37 in patients with prostate cancer.


  • Many with ED after prostate cancer don't seek help (Reuters via Yahoo! News)

    Many prostate cancer survivors who have sexual difficulties post-treatment have never tried erectile dysfunction therapies, such as Viagra, a new study shows.


  • Back to Prostate News Archive